Is APOE--epsilon4 a risk factor for cognitive impairment in normal aging?

Area of Science:

• Neuroscience
• Genetics
• Gerontology

Background:

• The apolipoprotein E (APOE) gene, particularly the epsilon4 allele, has been investigated for its potential role in cognitive aging.
• Previous research suggests a possible link between APOE genotype and cognitive function, but findings in healthy aging populations require further clarification.

Purpose of the Study:

• To investigate the association between APOE genotype and cognitive performance in a cohort of healthy older adults.
• To determine if age or the presence of chronic diseases, such as cardiovascular disease and diabetes, moderates the relationship between APOE genotype and cognition.

Main Methods:

• A cross-sectional study of 413 older adults (mean age 72.90 years) from the Charlotte County Healthy Aging Study.
• Participants underwent cognitive assessments measuring episodic memory, implicit memory, psychomotor speed, and attention.
• APOE genotyping and health status (including cardiovascular disease and diabetes) were evaluated.

Main Results:

• No significant differences in cognitive functioning were observed between individuals with and without the APOE-epsilon4 allele across all measured domains.
• Age and gender showed some significant differences in specific cognitive domains, but did not moderate the APOE-epsilon4 effect.
• Cardiovascular disease and diabetes did not significantly alter the relationship between APOE genotype and cognitive performance.

Conclusions:

• The presence of the APOE-epsilon4 allele was not found to be a risk factor for cognitive impairment in this sample of healthy older adults.
• Neither advanced age nor the presence of common chronic conditions significantly moderated the impact of APOE genotype on cognitive outcomes.
• These findings suggest that APOE genotype may not play a substantial role in cognitive aging among individuals without dementia.